-+ 0.00%
-+ 0.00%
-+ 0.00%

LEADS BIOLABS' PD-L1/4-1BB BISPECIFIC ANTIBODY OPAMTISTOMIG (LBL-024) GRANTED ORPHAN DRUG DESIGNATION IN JAPAN, FURTHER EXPANDING GLOBAL REGULATORY RECOGNITION

Reuters·09/28/2026 06:49:58

Please log in to view news